Date:
July 31, 2026
Content:
The U.S. Food and Drug Administration (FDA) has issued a Form 483 to Cascade Specialty Pharmacy LLC, located in Poulsbo, Washington, following a recent inspection of the facility.
On July 17, 2026, FDA investigators concluded their inspection of the compounding pharmacy, resulting in the issuance of official observations. A Form 483 is typically provided to a firm’s management at the close of an inspection when investigators have observed conditions that may constitute violations of the Food, Drug, and Cosmetic Act.
Cascade Specialty Pharmacy LLC, identified by FEI number 3015133983, is categorized as a production establishment. While the specific details of the observations are detailed in the 483 document, the issuance serves as a notice for the firm to address and rectify potential quality control or safety concerns identified by federal regulators.
Source: FDA OII FOIA Electronic Reading Room
Link:
http://www.fda.gov/about-fda/fda-commissioner/cascade-specialty-pharmacy-llc-poulsbo-wa-483-issued-07172026
Keywords:
FDA, Form 483, Cascade Specialty Pharmacy LLC, Poulsbo, Washington, Pharmacy Inspection, Drug Compounding